Suchergebnisse - Peter Ellmark

Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform von Barnabas Nyesiga, Karin Hägerbrand, Laura Varas, Anette Gjörloff Wingren, Mats Ohlin, Peter Ellmark, Laura von Schantz

Volltext

First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies von Peter Ellmark, Jeffrey Yachnin, Ana Carneiro, Lena Schultz, Amanda Hahn, Sumeet Ambarkhane, Karin Enell Smith, Gustav J. Ullenhag

Volltext

839 Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer von Peter Ellmark, Milad Abolhalaj, Kristina Lundberg, Karin Hägerbrand, Carl Borrebaeck, Viktor Sincic, Henrik Lilljebjörn, Alar Aab, Thoas Fioretos, Fredrik Liedberg

Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody von Hampus Andersson, Aastha Sobti, David Gomez Jimenez, Yago Pico de Coaña, Sumeet Vijay Ambarkhane, Karin Hägerbrand, Karin Enell Smith, Malin Lindstedt, Peter Ellmark

Volltext

837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro von Malin Lindstedt, Peter Ellmark, Karin Hägerbrand, Sara Fritzell, Anette Sundstedt, David Gomez Jimenez, Anneli Nilsson, Lill Ljung, Mattias Levin, Mona Celander, Ida Uddbäck, Amulya Krishna Shetty, Hampus Andersson

Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes von Viktor Sincic, Ken F. Arlenhold, Sarah Richtmann, Henrik Lilljebjörn, Pontus Eriksson, Gottfrid Sjödahl, Mats Wokander, Karin Hägerbrand, Peter Ellmark, Thoas Fioretos, Carl A. K. Borrebaeck, Fredrik Liedberg, Kristina Lundberg

Volltext

CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1 von Jean-Luc Van Laethem, Karen Geboes, Ivan Borbath, Teresa Macarulla Mercade, Aurélien Lambert, Philippe Cassier, Hans Prenen, Emmanuel Mitry, Jean-Frédéric Blanc, Lorenzo Pilla, Jaime Feliu, Mercedes Rodriguez Garrote, Roberto Antonio Pazo-Cid, Inmaculada Gallego, Karin Enell Smith, Karin Nordbladh, David Gomez Jimenez, Peter Ellmark, Yago Pico de Coaña, Sumeet Vijay Ambarkhane, Gregory L. Beatty, Eileen M. O'Reilly

Volltext

REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer von Songul Kucukcelebi, Freek R. van ‘t Land, Sjoerd H. van der Burg, Ferry A. L. M. Eskens, Marjolein Y. V. Homs, Marcella Willemsen, Anne Onrust-van Schoonhoven, Nina E. M. Rozendaal, Amine Fellah, Disha Vadgama, Miranda Moskie, Koen Bezemer, Michail Doukas, Casper W. F. van Eijck, Ralph Stadhouders, Judith de Vos-Geelen, Aniek E. van Diepen, Ilona Enninga, Rob Meijer, Sumeet V. Ambarkhane, Peter Ellmark, Joachim G. J. V. Aerts, Christianne Groeneveldt, Casper H. J. van Eijck

Volltext